ArticleFunctional & integrative genomics2026

SLC2A1 promotes chemo-immunotherapy resistance in lung adenocarcinoma by modulating the AKT signaling pathway.

Jingsheng Ruan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.